These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9660450)

  • 1. Behavior in a mouse model of isolates of Leishmania donovani sensu lato cultured from the blood of patients with chronic cutaneous lesions.
    Nuwayri-Salti N; Matta M; Shbaklo Z; Lakkis M; Kabbani ZE
    Am J Trop Med Hyg; 1998 Jun; 58(6):710-4. PubMed ID: 9660450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.
    Kariyawasam KKGDUL; Selvapandiyan A; Siriwardana HVYD; Dube A; Karunanayake P; Senanayake SASC; Dey R; Gannavaram S; Nakhasi HL; Karunaweera ND
    Parasitology; 2018 Apr; 145(4):443-452. PubMed ID: 29113609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
    Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
    Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant natural infection with L. donovani and L. major: a case report from Iraq.
    al-Diwany LJ; al-Awkati NA; Atia M; Rassam MB
    Soz Praventivmed; 1995; 40(4):234-8. PubMed ID: 8525713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural hybrid of Leishmania infantum/L. donovani: development in Phlebotomus tobbi, P. perniciosus and Lutzomyia longipalpis and comparison with non-hybrid strains differing in tissue tropism.
    Seblova V; Myskova J; Hlavacova J; Votypka J; Antoniou M; Volf P
    Parasit Vectors; 2015 Nov; 8():605. PubMed ID: 26608249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.
    McCall LI; Zhang WW; Dejgaard K; Atayde VD; Mazur A; Ranasinghe S; Liu J; Olivier M; Nilsson T; Matlashewski G
    J Proteome Res; 2015 Feb; 14(2):1033-59. PubMed ID: 25536015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent infection with Leishmania donovani and Leishmania major in a Kenyan patient: clinical description and parasite characterization.
    Mebrahtu YB; Lawyer PG; Hendricks LD; Muigai R; Oster CN; Perkins PV; Koech DK; Pamba H; Roberts CR
    Am J Trop Med Hyg; 1991 Sep; 45(3):290-6. PubMed ID: 1928563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection.
    Zhang WW; Mendez S; Ghosh A; Myler P; Ivens A; Clos J; Sacks DL; Matlashewski G
    J Biol Chem; 2003 Sep; 278(37):35508-15. PubMed ID: 12829719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
    Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
    Front Immunol; 2018; 9():79. PubMed ID: 29459858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya.
    Mebrahtu YB; Van Eys G; Guizani I; Lawyer PG; Pamba H; Koech D; Roberts C; Perkins PV; Were JB; Hendricks LD
    Trans R Soc Trop Med Hyg; 1993; 87(5):598-601. PubMed ID: 8266420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK; Titus RG
    Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection.
    Campbell SA; Alawa J; Doro B; Henriquez FL; Roberts CW; Nok A; Alawa CB; Alsaadi M; Mullen AB; Carter KC
    Vaccine; 2012 Feb; 30(7):1357-63. PubMed ID: 22210224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease.
    Gicheru MM; Olobo JO; Anjili CO
    Exp Parasitol; 1997 Feb; 85(2):109-16. PubMed ID: 9030661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major.
    Zhang WW; Matlashewski G
    Mol Microbiol; 2004 Nov; 54(4):1051-62. PubMed ID: 15522086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.
    Rachamim N; Jaffe CL
    J Immunol; 1993 Mar; 150(6):2322-31. PubMed ID: 8450215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.
    Matte C; Olivier M
    J Infect Dis; 2002 Mar; 185(5):673-81. PubMed ID: 11865425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of BALB/c mice with Leishmania donovani derived lipophosphoglycan does not conver cross-protection to L. major infections.
    Tonui WK
    East Afr Med J; 2003 May; 80(5):260-3. PubMed ID: 16167742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An imported case of cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Japan.
    Ito K; Takahara M; Ito M; Oshiro M; Takahashi K; Uezato H; Imafuku S
    J Dermatol; 2014 Oct; 41(10):926-8. PubMed ID: 25228325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized cutaneous leishmaniasis due to Leishmania donovani and Leishmania tropica: preliminary findings of the study of 161 new cases from a new endemic focus in himachal pradesh, India.
    Sharma NL; Mahajan VK; Kanga A; Sood A; Katoch VM; Mauricio I; Singh CD; Parwan UC; Sharma VK; Sharma RC
    Am J Trop Med Hyg; 2005 Jun; 72(6):819-24. PubMed ID: 15964970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.